The Adverse Outcome Index, Weighted AOI, and Severity Index were previously developed to measure the incidence and severity of delivery-related adverse events. In this study, researchers assessed how labor and delivery patient safety bundles influenced delivery-associated outcomes.
The bundle included 24-hour attending presence, communication training, mandatory use of a labor partogram, fetal heart rate tracing interpretation training and regular feedback on delivery-associated outcomes pre- and post-intervention.
Highlighted below are three findings from the study.
1. More than 5,800 deliveries met the study’s criteria. Comparing the pre- and post-intervention periods, high-risk pregnancy was more common in the post-intervention period at 79.4 percent versus 73.5 percent.
2. Among high-risk pregnancies, there was a decrease in both the Modified Weighted Adverse Outcomes Index and the Modified Severity Index; but no difference in the Modified Adverse Outcomes Index.
3. For low-risk pregnancies, there was no significant difference in the levels for any of the three measured indices over the study period.
More articles on adverse events:
FDA identifies numerous Noxafil dosage errors, suggests safety tips
App allows Brigham and Women’s patients to report safety concerns in real time
10 most popular stories, studies on wrong-site surgeries and SSIs in 2015
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
